Sound Income Strategies »

Galectin Therapeutics shares owned by Sound Income Strategies

Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Sound Income Strategies from 13F filings

Historical chart of Sound Income Strategies investment in Galectin Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Galectin Therapeutics held by Sound Income Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galectin Therapeutics by Sound Income Strategies

Quarter filed Position value Share count Share price at filing
2024-03-31 $7.1k 3.0k 2.39
2023-12-31 $4.9k 3.0k 1.66
2023-09-30 $5.7k 3.0k 1.92
2023-06-30 $4.3k 3.0k 1.44
2023-03-31 $6.3k 3.0k 2.10

More positions owned by Sound Income Strategies

Hercules Technology Growth Capital (HTGC)
Sixth Street Specialty Lending (TSLX)
Golub Capital BDC (GBDC)
Ares Capital Corporation (ARCC)
Ishares Tr 0-5yr Hi Yl Cp (SHYG)
Owl Rock Capital Corporation (OBDC)
Pennantpark Floating Rate Capi (PFLT)
Vaneck Vectors Etf Tr Emerging Mkts Hi (HYEM)
Ishares Jp Mrgn Em Hi Bd (EMHY)
First Tr Exchng Traded Fd Vi Tcw Emerging Mkt (EFIX)
Tidal Etf Tr Sound Enhanced (FXED)
Tidal Etf Tr Sound Equity Inm (DIVY)
Lyondellbasell Industries N Shs - A - (LYB)
Omni (OMC)
International Business Machines (IBM)

View all positions for Sound Income Strategies

Top funds holding Galectin Therapeutics

Vanguard Group
Advisor Group Holdings
Geneos Wealth Management
Atria Wealth Solutions
Sontag Advisory
Cambridge Investment Research Advisors
Commonwealth Equity Services
Cutter & CO Brokerage
683 Capital Management
Horizon Kinetics Asset Management
D.A. Davidson & Co.
Stratos Wealth Partners
William Blair $ Company
Independent Advisor Alliance
Solutions 4 Wealth

View all funds holding Galectin Therapeutics